Cluster news
Kaluga Pharmaceutical Cluster: First Russian Cluster to Get ESCA Cluster Excellence Silver Certificate
On October 24-26, 2017 European Secretariat for Cluster Analysis (ESCA) experts visited Kaluga Pharmaceutical Cluster to audit the cluster management system and evaluate the cluster’s business activities on the basis of 30 key indicators.
The Ministry of Industry and Trade of the Russian Federation Issues License for Medicines’ Production to Novo Nordisk
On September 4, 2017 the Ministry of Industry and Trade of the Russian Federation issued a license to produce insulin finished dosage forms at Novo Nordisk OOO production facility in Grabtsevo industrial park, Kaluga Region. This is a major step in expansion of Novo Nordisk modern insulin production.
AstraZeneca begins manufacturing of the first targeted drug for lung cancer treatment in Russia
On September 8, international biopharmaceutical company AstraZeneca launched a new high-tech production process at its plant at Vorsino industrial park in Kaluga Region. One of the first drugs to be manufactured on the new line is osimertinib – an innovative targeted drug for treatment of lung cancer.
NovaMedica in Kaluga Region: groundbreaking ceremony
A solemn groundbreaking ceremony to build modern bio-pharmaceutical factory operated by NovaMedica OOO (Rusnano investment project) took place on May 30 in Vorsino Industrial Park, Kaluga Region.
Kaluga Pharmaceutical Cluster: Production Output Grows by RUR 27.5 billion, 63 Participants, New Promising Projects
PharmEvolution, the 3rd International Forum for Pharmaceutical Industry Development in Russia, was held on April 4, 2017 in Kaluga.
PharmEvolution 2017. Modern Technologies and Future Russian Developments
Is to be held in Kaluga on April 4, 2017. The event is to be attended by key pharmaceutical market players, including top officials from federal government agencies, representatives regional government institutions; top managers from pharmaceutical companies, R&D centers, innovative business incubators, distributors and insurance companies, pharmacy retail chains, trade associations, as well as lead analysts, investors, and experts.